194 related articles for article (PubMed ID: 27107937)
1. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
[TBL] [Abstract][Full Text] [Related]
2. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
3. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
4. OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
Yan J; Su H; Xu L; Wang C
PLoS One; 2013; 8(4):e60854. PubMed ID: 23593329
[TBL] [Abstract][Full Text] [Related]
5. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
6. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
7. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; Mercié P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
[TBL] [Abstract][Full Text] [Related]
8. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
9. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
Redmond WL; Weinberg AD
Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
[TBL] [Abstract][Full Text] [Related]
10. OX40 (CD134) and OX40L.
Gough MJ; Weinberg AD
Adv Exp Med Biol; 2009; 647():94-107. PubMed ID: 19760068
[TBL] [Abstract][Full Text] [Related]
11. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
12. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
13. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement.
Qin W; Hongya W; Yongjing C; Fang X; Yue M; Xuekun Z; Xiaozhong L; Xueguang Z
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):54-9. PubMed ID: 21143648
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
15. Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.
Cui D; Lv Y; Yuan X; Ruan G; Zhang Y; Yan C; Xu D; Lv M; Mao Y; Cao J; Jin J; Xie J
J Immunol Res; 2019; 2019():6804806. PubMed ID: 30944836
[TBL] [Abstract][Full Text] [Related]
16. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
[TBL] [Abstract][Full Text] [Related]
18. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Odobasic D; Ruth AJ; Oudin V; Kitching AR; Holdsworth SR
Nephrol Dial Transplant; 2019 Mar; 34(3):429-441. PubMed ID: 29939347
[TBL] [Abstract][Full Text] [Related]
19. OX40 signaling is involved in the autoactivation of CD4
Jiang J; Liu C; Liu M; Shen Y; Hu X; Wang Q; Wu J; Wu M; Fang Q; Zhang X
Arthritis Res Ther; 2017 Mar; 19(1):67. PubMed ID: 28320444
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
